Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 122Precursor Cell Lymphoblastic Leukemia-Lymphoma 108Myelodysplastic Syndromes 97Lymphoma, Non-Hodgkin 88Leukemia, Lymphocytic, Chronic, B-Cell 81Hodgkin Disease 81Multiple Myeloma 80Leukemia 72Lymphoma, Mantle-Cell 62Lymphoma, Follicular 58Lymphoma 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 55Myeloproliferative Disorders 52Lymphoma, B-Cell, Marginal Zone 52Lymphoma, Large B-Cell, Diffuse 48Burkitt Lymphoma 48Leukemia, Myelomonocytic, Chronic 47Congenital Abnormalities 41Hematologic Neoplasms 37Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Accelerated Phase 34Waldenstrom Macroglobulinemia 33Leukemia, Myeloid, Chronic-Phase 33Anemia, Refractory, with Excess of Blasts 32Primary Myelofibrosis 31Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Lymphoma, Large-Cell, Anaplastic 26Leukemia, Biphenotypic, Acute 26Dendritic Cell Sarcoma, Interdigitating 26

Interventions

Stem Cell Transplantation 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Rituximab 1Mycophenolic Acid 1Muromonab-CD3 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Antilymphocyte Serum 1Antibodies 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemoglobinuria × Whole-Body Irradiation × Clear all
NCT00186823 2009-01-29

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 3 Completed
57 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡